FDA Inspection 1105245 — Andrea Rinke, M.D.
The FDA completed an inspection of Andrea Rinke, M.D. on October 20, 2017 in Bochum. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 20, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bochum (Germany)
Additional Details
Clinical Investigator (CI)